home / stock / gsk / gsk articles

GSK Articles, GlaxoSmithKline PLC - From 06/03/24

Stock Information
Company Name: GlaxoSmithKline PLC
Stock Symbol: GSK
Market: NYSE
Website: gsk.com
Menu
GSK GSK Quote GSK Short GSK News GSK Articles GSK Message Board
Get GSK Alerts

News, Short Squeeze, Breakout and More Instantly...
GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated Multiple Myeloma | Benzinga

On Sunday, GSK plc (NYSE:GSK) released results from an interim analysis of the DREAMM-8 phase 3 head-to-head trial evaluating Blenrep (belanta...
Why GameStop Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of GameStop Corp. (NYSE:GME) rose sharply in today's pre-market trading . The rally in the stock came on the back of Keith Gill, also k...

AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report | Benzinga

Western pharmaceutical companies and investors are driving a record number of licensing deals with Chinese drugmakers struggling to fund late-stage...

Zantac Verdict: Jury Finds No Link To Colon Cancer In Initial Trial, GSK And Boehringer Prevail In First Zantac Cancer Lawsuit | Benzinga

A Chicago jury rejected an Illinois woman’s claim that the discontinued heartburn drug Zantac caused her colon cancer. This case is the first...
First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential | Benzinga

Wednesday, Sanofi SA (NASDAQ:SNY) reported results from the Phase 2 study of oral rilzabrutinib in adult patients wit...

GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims | Benzinga

GSK Plc (NYSE:GSK) has been reportedly sued by an independent Connecticut laboratory, Valisure, accusing the pharmaceutical giant of...

GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows | Benzinga

Tuesday, GSK plc (NYSE:GSK) released headline results from the phase III clinical trials SWIFT-1 and SWIFT-2, which assessed th...
GSK Completely Exits Sensodyne Toothpaste Maker Haleon In $1.6B Sale | Benzinga

GSK plc (NYSE:GSK) confirmed the sale of 385.3 million shares in Haleon plc (NYSE:HLN) for $1.58 billion. The shares represented around 4.2% o...

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game | Benzinga

On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a...

Amazon Pours ~$1.3B Investment Into French Operations: Report | Benzinga

E-commerce giant Amazon.com Inc (NASDAQ:AMZN) is reportedly making a significant investment exceeding €1.2 billion ($1.3 billion) ...
Previous 10 Next 10